{"resourceType":"ValueSet","id":"1.3.6.1.4.1.6997.4.1.2.234.999.2","meta":{"versionId":"3","lastUpdated":"2015-08-26T01:00:02.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2","version":"20150826","name":"Selected urine screening for patients receiving opioid therapy","status":"active","date":"2015-08-26T01:00:02-04:00","publisher":"ECRI Steward","compose":{"include":[{"system":"http://loinc.org","version":"2.72","concept":[{"code":"19295-5","display":"Opiates [Presence] in Urine by Screen method"},{"code":"2112-1","display":"Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine"},{"code":"51782-1","display":"Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method"},{"code":"65750-2","display":"Drugs of abuse 5 panel - Urine by Screen method"}]}]}}